Sakar Healthcare Valuation
| SAKAR Stock | 286.25 1.40 0.49% |
At this time, the company appears to be overvalued. Sakar Healthcare has a current Real Value of USD231.86 per share. The regular price of the company is USD286.25. Our model measures the value of Sakar Healthcare from inspecting the company fundamentals such as Return On Equity of 0.049, operating margin of 0.15 %, and Price To Sales of 3.77 X as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 2.3617 | Enterprise Value 7 B | Enterprise Value Ebitda 17.1625 | Price Sales 3.7727 | Trailing PE 53.8064 |
Overvalued
Today
Please note that Sakar Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Sakar Healthcare is based on 3 months time horizon. Increasing Sakar Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Sakar Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sakar Stock. However, Sakar Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 286.25 | Real 231.86 | Hype 284.81 | Naive 276.93 |
The intrinsic value of Sakar Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sakar Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sakar Healthcare Limited helps investors to forecast how Sakar stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sakar Healthcare more accurately as focusing exclusively on Sakar Healthcare's fundamentals will not take into account other important factors: Sakar Healthcare Cash |
|
Sakar Healthcare Total Value Analysis
Sakar Healthcare Limited is at this time forecasted to have takeover price of 6.98 B with market capitalization of 6.23 B, debt of 793.52 M, and cash on hands of 933 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sakar Healthcare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.98 B | 6.23 B | 793.52 M | 933 K |
Sakar Healthcare Investor Information
The book value of the company was at this time reported as 243.8. The company recorded earning per share (EPS) of 5.32. Sakar Healthcare had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Sakar Healthcare's historical financial statements, Sakar Healthcare Limited is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 150.3 M | 244.7 M |
|
| |||||
| Operating Income | 520.3 M | 495.5 M |
|
|
Sakar Healthcare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sakar Healthcare has an asset utilization ratio of 39.01 percent. This suggests that the Company is making USD0.39 for each dollar of assets. An increasing asset utilization means that Sakar Healthcare Limited is more efficient with each dollar of assets it utilizes for everyday operations.Sakar Healthcare Profitability Analysis
The company reported the revenue of 1.54 B. Net Income was 116.71 M with profit before overhead, payroll, taxes, and interest of 604.47 M.About Sakar Healthcare Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Sakar Healthcare Limited. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Sakar Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Sakar Healthcare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Sakar Healthcare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sakar Healthcare. We calculate exposure to Sakar Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sakar Healthcare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 699.6 M | 377.4 M |
Sakar Healthcare Quarterly Retained Earnings |
|
Other Information on Investing in Sakar Stock
Sakar Healthcare financial ratios help investors to determine whether Sakar Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sakar with respect to the benefits of owning Sakar Healthcare security.